Logo

Course

Hepatitis C and Injection Drug Use

Details

Published Date: 05/24/2022

Expiration Date: 12/14/2024

CE Credit: No CE

Description

This course will discuss the importance of treating HCV among people who inject drugs (PWID). It will highlight and describe why PWID are a priority population for enhancing HCV prevention, screening and linkage to care and treatment. It will review the epidemiology of HCV among PWID, HCV transmission and the role of injection drug use in transmission, the efficacy of current direct acting antivirals for this population and discuss innovative strategies and models of HCV care for PWID.

Disclaimer

Effective June 27, 2023 the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) announced a one-time requirement of 8 hours of training on the treatment and management of patients with opioid or other substance use disorders for practitioners who are applying for or renewing their DEA license. This 1-hour ACCME-accredited course meets the DEA/SAMHSA requirement.

Presenter(s)

Anthony Martinez,MD, AAHIVS, FAASLD

Anthony Martinez, MD, AAHIVS, FAASLD is an associate professor of medicine at the University at Buffalo and medical director of hepatology at Erie County Medical Center. His clinic, “La Bodega,” has been recognized nationally and internationally as a novel co-localized model for managing viral hepatitis and addiction disorders. Dr. Martinez has lectured worldwide on Hepatitis C management among people with substance use disorders, and his team’s work has been presented at the annual liver meeting of the American Association for the Study of Liver, the annual conference of the International Network On Viral Hepatitis in Substance Users and at the International Liver Congress. He has been a primary and co-investigator on numerous clinical trials related to hepatitis C and fatty liver disease. He is board-certified by the ABIM and the American Academy of HIV Medicine. He is a Fellow of the American Association for the Study of Liver Disease, ambassador and co-chair of the Chronic Liver Disease Foundation HCV Committee, and an inductee in the Gold Humanism Honor Society.

Learning Objectives

  • Review the epidemiology of HCV among people who inject drugs (PWID).
  • Describe HCV transmission among PWID and the role of injection drug use in HCV transmission.
  • Discuss the importance of treating PWID and available treatment regimens.
  • Summarize innovative strategies/models of HCV care for PWID.

Continuing Education Credit Information